198 related articles for article (PubMed ID: 35013382)
1. The sphingosine 1-phosphate receptor 2/4 antagonist JTE-013 elicits off-target effects on sphingolipid metabolism.
Pitman MR; Lewis AC; Davies LT; Moretti PAB; Anderson D; Creek DJ; Powell JA; Pitson SM
Sci Rep; 2022 Jan; 12(1):454. PubMed ID: 35013382
[TBL] [Abstract][Full Text] [Related]
2. Blockage of sphingosine-1-phosphate receptor 2 attenuates allergic asthma in mice.
Park SJ; Im DS
Br J Pharmacol; 2019 Apr; 176(7):938-949. PubMed ID: 30706444
[TBL] [Abstract][Full Text] [Related]
3. Blockage of sphingosine-1-phosphate receptor 2 attenuates 2,4-dinitrochlorobenzene-induced atopic dermatitis in mice.
Park SJ; Im DS
Acta Pharmacol Sin; 2020 Nov; 41(11):1487-1496. PubMed ID: 32457418
[TBL] [Abstract][Full Text] [Related]
4. Antitumor Activity of a Novel Sphingosine-1-Phosphate 2 Antagonist, AB1, in Neuroblastoma.
Li MH; Swenson R; Harel M; Jana S; Stolarzewicz E; Hla T; Shapiro LH; Ferrer F
J Pharmacol Exp Ther; 2015 Sep; 354(3):261-8. PubMed ID: 26105954
[TBL] [Abstract][Full Text] [Related]
5. Sphingosine 1-phosphate counteracts insulin signaling in pancreatic β-cells via the sphingosine 1-phosphate receptor subtype 2.
Japtok L; Schmitz EI; Fayyaz S; Krämer S; Hsu LJ; Kleuser B
FASEB J; 2015 Aug; 29(8):3357-69. PubMed ID: 25911610
[TBL] [Abstract][Full Text] [Related]
6. Opposing Roles of Sphingosine 1-Phosphate Receptors 1 and 2 in Fat Deposition and Glucose Tolerance in Obese Male Mice.
Asano M; Kajita K; Fuwa M; Kajita T; Mori I; Akahoshi N; Ishii I; Morita H
Endocrinology; 2023 Jan; 164(3):. PubMed ID: 36690339
[TBL] [Abstract][Full Text] [Related]
7. S1P2 receptor mediates sphingosine-1-phosphate-induced fibronectin expression via MAPK signaling pathway in mesangial cells under high glucose condition.
Liu W; Lan T; Xie X; Huang K; Peng J; Huang J; Shen X; Liu P; Huang H
Exp Cell Res; 2012 May; 318(8):936-43. PubMed ID: 22406263
[TBL] [Abstract][Full Text] [Related]
8. The sphingosine-1-phosphate/sphingosine-1-phosphate receptor 2 axis regulates early airway T-cell infiltration in murine mast cell-dependent acute allergic responses.
Oskeritzian CA; Hait NC; Wedman P; Chumanevich A; Kolawole EM; Price MM; Falanga YT; Harikumar KB; Ryan JJ; Milstien S; Sabbadini R; Spiegel S
J Allergy Clin Immunol; 2015 Apr; 135(4):1008-1018.e1. PubMed ID: 25512083
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine 1-phosphate accelerates wound healing in diabetic mice.
Kawanabe T; Kawakami T; Yatomi Y; Shimada S; Soma Y
J Dermatol Sci; 2007 Oct; 48(1):53-60. PubMed ID: 17643267
[TBL] [Abstract][Full Text] [Related]
10. Ligand-dependent inhibition of B16 melanoma cell migration and invasion via endogenous S1P2 G protein-coupled receptor. Requirement of inhibition of cellular RAC activity.
Arikawa K; Takuwa N; Yamaguchi H; Sugimoto N; Kitayama J; Nagawa H; Takehara K; Takuwa Y
J Biol Chem; 2003 Aug; 278(35):32841-51. PubMed ID: 12810709
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of S1P Receptor 2 Attenuates Endothelial Dysfunction and Inhibits Atherogenesis in Apolipoprotein E-Deficient Mice.
Ganbaatar B; Fukuda D; Shinohara M; Yagi S; Kusunose K; Yamada H; Soeki T; Hirata KI; Sata M
J Atheroscler Thromb; 2021 Jun; 28(6):630-642. PubMed ID: 32879149
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target.
Sukocheva OA; Furuya H; Ng ML; Friedemann M; Menschikowski M; Tarasov VV; Chubarev VN; Klochkov SG; Neganova ME; Mangoni AA; Aliev G; Bishayee A
Pharmacol Ther; 2020 Mar; 207():107464. PubMed ID: 31863815
[TBL] [Abstract][Full Text] [Related]
13. Sphingosine 1-phosphate lyase blockade elicits myogenic differentiation of murine myoblasts acting via Spns2/S1P
Cencetti F; Bruno G; Bernacchioni C; Japtok L; Puliti E; Donati C; Bruni P
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Sep; 1865(9):158759. PubMed ID: 32565314
[TBL] [Abstract][Full Text] [Related]
14. Sphingosine-1-Phosphate Enhances α
Panta CR; Ruisanchez É; Móré D; Dancs PT; Balogh A; Fülöp Á; Kerék M; Proia RL; Offermanns S; Tigyi GJ; Benyó Z
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31861195
[TBL] [Abstract][Full Text] [Related]
15. JTE-013 Alleviates Inflammatory Injury and Endothelial Dysfunction Induced by Sepsis In Vivo and In Vitro.
Xu Q; Chen J; Zhu Y; Xia W; Liu Y; Xu J
J Surg Res; 2021 Sep; 265():323-332. PubMed ID: 33971464
[TBL] [Abstract][Full Text] [Related]
16. Blocking sphingosine 1-phosphate receptor 2 accelerates hepatocellular carcinoma progression in a mouse model of NASH.
Yoshida T; Tsuchiya A; Kumagai M; Takeuchi S; Nojiri S; Watanabe T; Ogawa M; Itoh M; Takamura M; Suganami T; Ogawa Y; Terai S
Biochem Biophys Res Commun; 2020 Oct; 530(4):665-672. PubMed ID: 32768187
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine 1-phosphate receptor 2 antagonist JTE-013 increases the excitability of sensory neurons independently of the receptor.
Li C; Chi XX; Xie W; Strong JA; Zhang JM; Nicol GD
J Neurophysiol; 2012 Sep; 108(5):1473-83. PubMed ID: 22673325
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of pyrazolopyridine derivatives as sphingosine 1-phosphate receptor 2 ligands.
Luo Z; Yue X; Yang H; Liu H; Klein RS; Tu Z
Bioorg Med Chem Lett; 2018 Feb; 28(3):488-496. PubMed ID: 29249563
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor-induced cellular invasion requires sphingosine-1-phosphate/sphingosine-1-phosphate 2 receptor-mediated ezrin activation.
Orr Gandy KA; Adada M; Canals D; Carroll B; Roddy P; Hannun YA; Obeid LM
FASEB J; 2013 Aug; 27(8):3155-66. PubMed ID: 23629860
[TBL] [Abstract][Full Text] [Related]
20. Activation of sphingosine 1-phosphate receptor 2 attenuates chemotherapy-induced neuropathy.
Wang W; Xiang P; Chew WS; Torta F; Bandla A; Lopez V; Seow WL; Lam BWS; Chang JK; Wong P; Chayaburakul K; Ong WY; Wenk MR; Sundar R; Herr DR
J Biol Chem; 2020 Jan; 295(4):1143-1152. PubMed ID: 31882542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
